CST3 and cancer: Of the 29 enriched proteins, only two are described as inhibiting cancer cell growth and migration, as well as causing lysosomal/mitochondrial dysfunction and increasing apoptosis: cystatin C (through its inhibition of cathepsins) [68] and decorin [69].